接受系统性治疗的银屑病患者严重感染多变量风险预测模型的开发与验证
该研究利用英国皮肤科医师协会生物干预登记处(BADBIR)开发银屑病患者启动系统性治疗后1年内严重感染的风险预测模型,并在德国PsoBest登记处进行外部验证。BADBIR中175/10033例(1.7%)和PsoBest中41/2423例(1.7%)发生严重感染。模型内部性能尚可但外部验证性能差,作者认为该模型可能有助于英国和爱尔兰的患者与皮肤科医生识别可改变的风险因素并在共享决策中指导治疗选择。
要点
- BADBIR中175/10033例(1.7%)在启动系统性治疗后1年内发生严重感染。
- PsoBest中41/2423例(1.7%)在启动系统性治疗后1年内发生严重感染。
- 模型外部验证性能差:C统计量0.52(95%CI 0.42-0.62),校准斜率0.36(95%CI -0.24-0.97)。
核心结论
- 作者报告了多变量预测模型开发的首批结果,该模型可能有助于英国和爱尔兰的患者与皮肤科医生识别可改变的风险因素并在共享决策中指导治疗选择。
研究设计与样本
- 风险预测模型使用英国皮肤科医师协会生物干预登记处(BADBIR)开发,并以德国银屑病登记处PsoBest作为验证数据集。
- 采用C统计量、校准斜率和校准-in-the-large在内部和外部评估模型区分度与校准度。
主要发现
- BADBIR的10033例参与者中175例(1.7%)在启动治疗后1年内发生严重感染,PsoBest的2423例参与者中41例(1.7%)发生严重感染。
- 多重逻辑回归模型纳入九个基线协变量,启动英夫利西单抗是最强预测因子。
- 内部评估显示bootstrap乐观校正C统计量0.64(95%CI 0.60-0.69),校准-in-the-large为0.02(95%CI -0.14至0.17),校准斜率0.88(95%CI 0.70-1.07)。
- 外部验证性能差:C统计量0.52(95%CI 0.42-0.62),校准-in-the-large为0.06(95%CI -0.25至0.37),校准斜率0.36(95%CI -0.24至0.97)。
局限性
- 外部验证性能差:C统计量0.52(95%CI 0.42-0.62),校准斜率0.36(95%CI -0.24至0.97)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with psoriasis are often concerned about the risk of serious infection associated with systemic psoriasis treatments. OBJECTIVES: To develop and externally validate a prediction model for serious infection in patients with psoriasis within 1 year of starting systemic therapies. METHODS: The risk prediction model was developed using the British Association of Dermatologists Biologic Interventions Register (BADBIR), and the German Psoriasis Registry PsoBest was used as the validation dataset. Model discrimination and calibration were assessed internally and externally using the C-statistic, the calibration slope and the calibration in the large. RESULTS: Overall 175 (1·7%) out of 10 033 participants from BADBIR and 41 (1·7%) out of 2423 participants from PsoBest developed a serious infection within 1 year of therapy initiation. Selected predictors in a multiple logistic regression model included nine baseline covariates, and starting infliximab was the strongest predictor. Evaluation of model performance showed a bootstrap optimism-corrected C-statistic of 0·64 [95% confidence interval (CI) 0·60-0·69], calibration in the large of 0·02 (95% CI -0·14 to 0·17) and a calibration slope of 0·88 (95% CI 0·70-1·07), while external validation performance was poor, with C-statistic 0·52 (95% CI 0·42-0·62), calibration in the large 0·06 (95% CI -0·25 to 0·37) and calibration slope 0·36 (95% CI -0·24 to 0·97). CONCLUSIONS: We present the first results of the development of a multivariable prediction model. This model may help patients and dermatologists in the U.K. and the Republic of Ireland to identify modifiable risk factors and inform therapy choice in a shared decision-making process.
引用
- Yiu ZZN, Sorbe C, Lunt M, et al. Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy. Br J Dermatol. 2019. PMID: 30430546. doi:10.1111/bjd.17421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。